China’s COVID-19 drugs pipeline focuses on new sub-variants, says GlobalData https://ift.tt/urKBIb1

As per GlobalData’s Pharma Intelligence Centre, there are 19 drugs in various phases of clinical development for the treatment of COVID-19 in China. Most of these drugs are targeting various subtypes of COVID-19 variants such as Delta and Omicron.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Jv3UnXe